Mehdi Latiri

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL).

Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL).

Journal: Leukemia

Published: January 28, 2025

ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.

ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.

Journal: Blood advances

Published: May 24, 2024

Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.

Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.

Journal: Cancer research

Published: January 11, 2024

DNA methylation as a new tool for the differential diagnosis between T-LBL and lymphocyte-rich thymoma.

DNA methylation as a new tool for the differential diagnosis between T-LBL and lymphocyte-rich thymoma.

Journal: The Journal of pathology

Published: October 20, 2023

Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.

Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.

Journal: Molecular cancer

Published: November 21, 2022

From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia.

From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia.

Journal: Nature communications

Published: September 22, 2022

Adenylate kinase 2 expression and addiction in T-ALL.

Adenylate kinase 2 expression and addiction in T-ALL.

Journal: Blood advances

Published: June 17, 2020

Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup.

Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup.

Journal: Science translational medicine

Published: April 27, 2020

Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia.

Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia.

Journal: Haematologica

Published: April 04, 2019

Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.

Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.

Journal: Blood advances

Published: November 20, 2018

Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.

Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 14, 2018

Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.

Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.

Journal: American journal of respiratory cell and molecular biology

Published: January 27, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026